Precision Oncology Today
Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis, treatment, and drug discovery.
Nanotechnology opens the door to a range of unique methods for sensing cancer biomarkers in body fluids, thanks to the unusual properties and capabilities of nanoscale systems. Going small promises big gains in diagnosing and tracking a wide range of tumors.
Trending on Inside Precision Medicine
A third positive Phase II trial will help Alto Neuroscience progress precision psychiatry treatments for depression to the clinic.
Research hospital Seattle Children’s announced today the spinout of its for-profit company BrainChild Bio, Inc., which will develop CAR T-cell therapies targeting pediatric central nervous system (CNS) cancers.